Received May 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 7NX57 | IM / LA |
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 1 | Z003701 | IM / RA |
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | 1 | Y1A212M | IM / RA |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | Y015022 | SC / LA |
| TDAP | TDAP (ADACEL) | SANOFI PASTEUR | N/A | U8366AA | IM / LA |
| TYP | TYPHOID VI POLYSACCHARIDE (TYPHIM VI) | SANOFI PASTEUR | N/A | X1A271M | IM / RA |
| YF | YELLOW FEVER (YF-VAX) | SANOFI PASTEUR | N/A | UK134AA | SC / RA |
Client was having conversation when he suddenly put his back and passed out. RN grabbed an ice pack. 911 called. After 10 seconds client jolted awake. Client appeared pale and diaphoresis. Client on awakening was confused about where he was. Client reorientated and moved to vaccine chair where his feet were elevated and put in supine position. Client's BP taken for 99/57 HR 74 at 1346. Client provided with water. ANS was informed about situation. Client BP retaken at 1405 for 100/65. Client stated he felt better and had no sign of diaphoresis. Client had more color to his face as well. Clients in for appointment with his friend who said he will be driving client home. Client's ICV updated. Client was watched for 30 mins post incident.
N/A
N/A
N/A
N/A